Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities    
Net income (loss) $ 36,326,199 $ (5,254,652)
Adjustments to reconcile net income (loss) to net cash used in operating activities    
Depreciation expense 8,260 12,753
Gain on debt extinguishment (40,802,730) (2,434,661)
Decrease in fair value of derivative liabilities 0 (948)
Amortization of discount on notes payable 1,261,156 2,064,774
Accrued interest on patents purchased 198,000 123,233
Amortization of patents and acquired contracts 776,745 1,217,985
Stock-based compensation 334,796 545,626
Changes in operating assets and liabilities    
Accounts receivable 14,824 8,880
Prepaid expenses and other current assets 440,518 (646,943)
Deferred expenses 97,409 (27,391)
Deposits and other assets (1,865) 0
Accounts payable 367,658 777,559
Accrued expenses and other current liabilities 221,563 407,267
Deferred revenue (1,246,429) 450,000
Net cash used in operating activities (2,003,896) (2,756,518)
Cash flows from financing activities    
Proceeds from issuance of preferred stock, net of issuance costs 0 5,221,998
Proceeds from issuance of common stock, net of issuance costs 0 1,182,278
Proceeds from short-term notes payable, related parties 530,000 0
Payments on senior notes payable 0 (1,640,016)
Redemption of preferred stock 0 (2,500,000)
Payments on related party note payable 0 (50,000)
Net cash provided by financing activities 530,000 2,214,260
Net decrease in cash and cash equivalents (1,473,896) (542,258)
Cash and cash equivalents, beginning of period 1,476,774 554,556
Cash and cash equivalents, end of period 2,878 12,298
Supplemental disclosures of cash flow information    
Cash paid for interest 0 613,600
Supplemental disclosures of non-cash investing and financing activities    
Fair value of common stock warrants $ 341,535 $ 4,154,620